Rethinking Clinical Trials

MARCH 28, 2024

Dr. Rosa Gonzalez-Guarda The NIH Pragmatic Trials Collaboratory’s Health Equity Core developed a written aid to offer guidance on inclusive language and terms to use when referring to specific people, groups, and communities. The Equitable Language Cheat Sheet is available on the Health Equity Core webpage and will be updated as terminology and guidance evolves.

Trials 219

Trials Nurses Clinical Trials Clinical Trials 219

Bio Pharma Dive

MARCH 28, 2024

Xilio will get just over $40 million from Gilead in return for a license to its experimental IL-12 immunotherapy. The biotech is also discontinuing other work and laying off staff.

Licensing 298

Licensing Licensing Drugs 298

Pharmaceutical Technology

MARCH 28, 2024

According to the CDC, over 64 cases of measles have been documented in the US in 2024, already exceeding 2023's total of 58.

Vaccination 284

Vaccination Vaccine 284

Bio Pharma Dive

MARCH 28, 2024

The agency gave Akebia’s drug an OK after receiving more safety data, but imposed a strict boxed warning for its use that may limit uptake.

FDA Approval 290

FDA Approval Drugs 290

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharmaceutical Technology

MARCH 28, 2024

Nanoscope Therapeutics released promising top-line results for its RESTORE trial, which is studying the gene therapy MCO-010 in patients with retinitis pigmentosa (RP).

Gene Therapy 246

Gene Therapy Gene Trials 246

Bio Pharma Dive

MARCH 28, 2024

With Zola Therapeutics, Krieg plans to design and sell a series of cancer immunotherapies without the help of outside investors, he told BioPharma Dive.

Drugs 195

Drugs 195

Bio Pharma Dive

MARCH 28, 2024

Novo Nordisk’s acquisition of Cardior Pharmaceuticals is a bet on new approaches to cardiovascular disease, says Cardior head Claudia Ulbrich.

162

162

Pharmaceutical Technology

MARCH 28, 2024

AI is fast becoming a valuable tool for developers of regulated health apps. In an exclusive Q&A, SaMD solutions provider Huma tells us how AI is allowing clinicians to make better decisions and why the human factor will remain a critical element of healthcare.

Regulation 147

Regulation Development 147

Pharma Times

MARCH 28, 2024

Healthcare agencies can submit their entries free of charge with a deadline of 30 April

134

134

Fierce Pharma

MARCH 28, 2024

An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S. | An alleged development in the national security crackdown against WuXi AppTec and a handful of other Chinese companies in the U.S. suggests intelligence officials and lawmakers may have good reason to be concerned about the CDMO’s potential political ties to its home country.

Development 130

Development 130

Advertisement

Clinical Supply

Pharma Times

MARCH 28, 2024

The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases

Development 133

Development 133

Pharmaceutical Technology

MARCH 28, 2024

Pharmaceutical Technology has listed the leading protein and peptide synthesis solutions and suppliers. Download for free here.

Protein 130

Protein Manufacturing 130

Pharma Times

MARCH 28, 2024

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m

Research 121

Research Medicine 121

Pharmaceutical Technology

MARCH 28, 2024

RLS-0071 is being evaluated for the treatment of radiation poisoning, which can cause damage to the gastrointestinal tract.

Development 130

Development Drugs 130

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Fierce Pharma

MARCH 28, 2024

Johnson & Johnson will get a do-over in its defense against more than 50,000 lawsuits that claim the company’s iconic baby powder can cause ovarian cancer. | Johnson & Johnson will get a do-over in its defense against more than 50,000 lawsuits claiming that the company’s iconic baby powder can cause ovarian cancer. A New Jersey court ruled on Wednesday that J&J can contest the scientific findings that back those cases.

115

115

Pharmaceutical Technology

MARCH 28, 2024

View the Leading Pharmaceutical Compounding Companies in Contract Manufacturing for the Pharmaceutical Industry. Download Free Guide Here.

Contract Manufacturing 130

Contract Manufacturing Manufacturing 130

pharmaphorum

MARCH 28, 2024

Explore the cutting-edge innovations featured at WIRED Health 2024, including insights on Alphafold, clean air technology, and Lingo. Stay informed about the latest disruptors shaping the future.

114

114

Pharmaceutical Technology

MARCH 28, 2024

Drug shortages are worsening globally, leaving patients without access to essential medications, and healthcare providers struggling to find alternative treatments.

Drugs 130

Drugs 130

Advertisement

Clinical Supply

pharmaphorum

MARCH 28, 2024

Scientists say a test for motor neuron disease, based on an aptamer for biomarker TDP-43 in brain tissue, could detect at-risk people before symptoms develop.

Scientist 111

Scientist Development 111

Pharmaceutical Technology

MARCH 28, 2024

Under the agreement, Xilio Therapeutics may receive up to $604 million from Gilead Sciences in additional payments.

Development 130

Development 130

pharmaphorum

MARCH 28, 2024

Moderna’s development of mRNA vaccines for influenza will be backed by up to $750m in funding from Blackstone in a risk-sharing deal

Vaccination 109

Vaccination Vaccine Development 109

Pharmaceutical Technology

MARCH 28, 2024

Licensing agreements for innovator drugs utilising clustered regularly interspaced short palindromic repeats (CRISPR) technologies saw oncology, immunology, and central nervous system as the top three therapy areas by total deal value with a combined $21bn over the past five years.

Licensing 130

Licensing Licensing Drugs 130

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

pharmaphorum

MARCH 28, 2024

New data for Beckley Psytech's psychedelic therapy for treatment-resistant depression builds anticipation for a phase 2b readout later this year

105

105

Pharmaceutical Technology

MARCH 28, 2024

Pharmaceutical Technology Has Listed the Leading Lab Equipment Suppliers to Assist in Lab Equipment Procurement. Download for Free Here.

130

130

XTalks

MARCH 28, 2024

Italy-based drugmaker Italfarmaco has won US Food and Drug Administration (FDA) approval for its oral medication Duvyzat (givinostat) for the treatment of Duchenne muscular dystrophy (DMD) in patients six years of age and older. Duvyzat, a histone deacetylase (HDAC) inhibitor that works to reduce inflammation and muscle loss, is the first nonsteroidal drug approved to treat patients with all genetic variants of DMD.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

Pharmaceutical Technology

MARCH 28, 2024

Discover a groundbreaking patent for treating atypical teratoid/rhabdoid tumors with HydroxyUreaMethyl Acylfulvene. Learn how this method targets SMARCB1 gene alterations and enhances efficacy with radiation therapy. Explore the potential of this innovative treatment option today.

Gene 130

Gene 130

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

XTalks

MARCH 28, 2024

In recent years, the food industry has faced growing scrutiny over its environmental impact, particularly concerning the use of plastic packaging. This scrutiny has sparked significant interest and investment in alternative packaging solutions, with edible food packaging emerging as a particularly innovative and sustainable option. In this episode of the Xtalks Food Podcast, Sydney talks about the rise of edible food packaging and the technologies and types of edible packaging available.

Packaging 105

Packaging Packaging Production Development 105

Pharmaceutical Technology

MARCH 28, 2024

Discover the groundbreaking patent by Pieris Pharmaceuticals Inc for novel muteins derived from human lipocalin 2, targeting Alzheimer's disease and tumor neovasculature. Explore the potential of these muteins in diagnostics, therapeutics, and research.

Research 130

Research 130

Pharmaceutical Commerce

MARCH 28, 2024

The latest news for pharma industry insiders.

Production 105

Production 105

Pharmaceutical Technology

MARCH 28, 2024

Discover a groundbreaking method for treating PCOS-FAH with a CRF1 antagonist, targeting adrenal androgens to alleviate symptoms like hirsutism and infertility. Patent US11858932B2 offers new compounds and effective management strategies.

130

130

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials